News & Updates

A study suggests that in choosing CDK4/6 inhibitors (palbociclib and abemaciclib) for patients with hormone receptor-positive, HER2-negative metastatic/recurrent breast cancer, considerations must be made based on the tolerability and manageability of adverse events (AEs).

Urea is as effective as tolvaptan in the treatment of hyponatremia, with a lower incidence of overcorrection, as shown in a study.

Weight loss interventions help improve some features of polycystic ovary syndrome (PCOS), making it a potential treatment option for women with PCOS, suggests a study.

Individuals with worsening chronic kidney disease (CKD) are at greater risk for emergently treated hypocalcemia with denosumab, and the highest risk is observed among dialysis-dependent (DD) patients and those with CKD–mineral and bone disorder (CKD-MBD), reveals a study.